assessment of Jalakumbhi Panchanga Bhasma along with Pippali Churna in the patients of Hypothyriodism

Phase 2

• Conditions: Health Condition 1: E039- Hypothyroidism, unspecified

• Registration Number: CTRI/2022/09/045725
• Lead Sponsor: Department of Kayachiktsa Faculty of Ayurveda Institute of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Willing to give consent to participate in the study.

2. Patients in age group between 30-60 years of either sex.

3. Patients positive for Zulewskiââ?¬•s clinical score for hypothyroidism.

4. Patient fulfilling the laboratory diagnosis of hypothyroidism on the basis of serum TSH, T3 and T4 levels.

5. Patients having uncontrolled TSH level in spite adequate doses of Levothyroxine.

Exclusion Criteria

1. Patients age <30 or >60 years.

2. Patients with ischemic heart disease, uncontrolled hypertension, myocardial infarction, cerebrovascular event, cardiac arrhythmias, pregnancy and active malignant disease were excluded from the study.

3. Patients with altered thyroid hormone levels due to other conditions such as undernutrition, malignant neoplasm or non-thyroidal illness (low-T3 syndrome).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Thyroid profile <br/ ><br>2.Lipid profile <br/ ><br>3.Complete blood countTimepoint: Before drug trail and after drug trail i.e.,after 3 months

Secondary Outcome Measures

Name	Time	Method
Agni assessmentTimepoint: Three month before and after trail;WHO QOL BreifTimepoint: Three month before and after trail